This issue contains two observational studies 1,2 and a single-centre randomised trial 3 offering insights into the complexities of care of the critically ill, the peri-operative care of the high risk patient and the application of monitoring technologies.
Shock has been described as "the rude unhinging of the machinery of life" and fluid resuscitation is an integral part of the supportive therapy 5 . Defining what type of fluid and how much to give has been a subject of controversy and debate 6 . There is increasing recognition that administered fluid, like any medication, has adverse effects associated with underdosing and excess 7 . The clinical assessment of haemodynamic variables such as cardiac output is poor. However, large, well conducted multicentre trials have shown that invasive assessment of the circulation using a pulmonary artery catheter offers no advantage over care provided by the use of central venous and arterial catheters with or without detailed management protocols 8, 9 . Therefore, as Baker and colleagues state, a non-invasive method of assessing the likelihood of fluid responsiveness would be highly desirable 10 .
There has been a large amount of interest in the use of the plethysmographic variability index (PVI) in the operating room and to a lesser extent in the intensive care unit. The development of PVI methods and recent references are available 11 . The non-invasive nature and the ease of application make the concept attractive. It would also seem that this device makes fewer assumptions about the characteristics of the arterial system and arterial impedance compared to methods using analysis of the arterial waveform and, compared to oesophageal Doppler, does not assume that a fixed proportion of the cardiac output traverses the descending aorta. It also does not require the technical skills and equipment needed with echocardiography, but of course provides no anatomical information [12] [13] [14] .
In a detailed analysis, Baker et al showed that a static single haemodynamic measurement was not useful in predicting fluid responsiveness in a subset of intensive care unit patients who were mechanically ventilated with lung protective tidal volumes and were receiving a noradrenaline infusion 1 .
They did show that when PVI decreases after fluid administration the cardiac output generally increases ( Figure 2 in the study by Baker et al). However, with this sample size, it is possible that a small number of data points may be quite influential in the shape of the curve and confidence intervals are large. From the study design, we don't know who didn't get fluid and might have needed it. We also don't know if the addition of fluid might have allowed a reduction in noradrenaline dose. Dobutamine is a confounder and is presumably used in patients with clinical or investigation-based markers of decreased cardiac output.
Fluid titration to macro-circulatory variables (blood pressure, cardiac output, mixed venous oxygen saturation) is a common practice; however, the relationship between macro-circulatory variables and micro-circulatory function, which is the main determinant of end-organ wellbeing is less certain in septic patients 15 . The time-dependent nature of fluid resuscitation should also be considered. Administering fluid during the early phase of shock may result in lower total volumes of fluid needed 16 . The lack of predictive ability of a single static measurement is not surprising 10 . If a pulmonary artery catheter is used as part of haemodynamic assessment, a reasonably common practice would be to set up a 'titration curve'. Aliquots of fluid would be given with repeated measurements of stoke volume/cardiac output, and the endpoints would typically be that fluid is given until the stroke volume stops increasing with increasing filling pressures or the desired cardiac output is achieved. It is possible that this may be the way the PVI should be used 17 . Future studies may consider the use of repeated measure designs to assess the response to therapy and which potentially would also have the beneficial effect of reducing sample sizes.
There is now evidence to support limiting tidal volumes in surgical patients in the operating room as well as the intensive care unit 18 . This may have implications for technologies that measure pulse pressure variation as algorithms may need review.
Baker and colleagues have given us further information on the complexities of fluid management in Anaesth Intensive Care 2013; 41: 706-709 Editorial Benefits of using ultrasound and non-invasive haemodynamic monitoring for critically ill and cardiac surgical patients the critically ill. Although predictive information from a 'snapshot' would be desirable we are not there yet. Perioperative care involves a synthesis of available clinical findings particularly the natural history of the underlying diagnosis together with data from investigations. The clinician integrates the information including response to therapy, risks and benefits and the stage of the illness into a management plan 19 .
In the second paper, Saranteas et al report on the incidence of inferior vena cava (IVC) thrombosis detected by transthoracic echocardiography in adult patients undergoing cardiac and general surgery 2 . All cardiac surgical patients routinely received a postoperative transthoracic echocardiogram in the first 24 hours, so potentially we know the true incidence in this sample and the variables obtained in a routine transthoracic echocardiogram imaging sequence are available. There is a paucity of information in this area as most IVC thrombus in cardiac surgery literature relates to the surgical management of advanced renal cell malignancy or very rare events such as Budd Chiari syndrome 20 . If we extrapolate from pulmonary embolism (PE) and deep venous thrombosis (DVT) literature, the clinical detection of DVT is low compared to the incidence detected by screening investigations such as ultrasound 21 . The reported incidence of DVT is controversial and varies from 16% to 48% of cases with proximal clot in 3.0% and PE vary from 0.5% to 3.0% after cardiac surgery 22 The authors were able to visualise the IVC in nearly 80% of cardiac surgery patients and 85% of general surgery patients. They identified eight patients with non-occlusive IVC thrombosis in a subset of 105 patients who had postoperative right ventricular dysfunction, which implies there was no IVC thrombosis in patients with normal right ventricular function. The eight patients with IVC thrombosis were a high-risk cohort with a mean logistic Euroscore of 32.5 and none under 10. In the general surgery cohort the incidence of IVC thrombus was 0.4% (1/250) with very limited clinical data provided.
The authors discuss Virchow's triad in the cardiac surgical patient. The right ventricular dysfunction would contribute to stasis. The intraoperative venous cannulation strategy is relevant as patients undergoing coronary artery bypass grafting would normally have a single right atrial venous cannula whereas patients undergoing tricuspid and mitral valve surgery would have a bicaval venous cannulation which may predispose to vessel wall injury. However, the third component, hypercoagulability, is usually not present in the first 24 hours after cardiac surgery due to platelet dysfunction and dilutional coagulopathy. none of the patients received cryoprecipitate, recombinant Factor VII or prothrombinex, but all received platelets and fresh frozen plasma. more detailed clinical preoperative and intraoperative information would be required in future studies. For example, were there additional risk factors for venous thrombosis such as preoperative hospitalisation for a significant period of time, what were the technical aspects of venous cannulation such as cannula size and type and were there features of IVC thrombus or stasis on an intraoperative echocardiogram? Additionally what was the cause of the inability to obtain transthoracic images? obesity is also a risk factor venous thrombosis 23 . In a high-risk patient who was mechanically ventilated postoperatively, transoesphageal echocardiography could be justified.
The current guidelines for DVT prophylaxis suggest that cardiac surgical patients are at intermediate risk compared to high-risk patients such as those undergoing lower limb arthroplasty and abdominal malignancy surgery 21 . This study suggests the opposite. The current drive to blood conservation practices may be of relevance in trying to minimise preoperative anticoagulation and antiplatelet therapies where possible 24 .
Future studies on the incidence of IVC thrombosis would need to consider not only the findings and their reliability but also what to do about the diagnosis 25 . Patients with mitral and tricuspid valve surgery and those with poor ventricular function often have an indication for long-term anticoagulation. The authors report in this series despite anticoagulation, one of the eight patients had a fatal pulmonary embolus. Thus the role of IVC filters would need consideration.
In the paper by Alvarez et al, the effects of dobutamine and levosimendan on measures of hepatic blood flow in patients with low cardiac output after cardiac surgery were compared 3 . The authors performed a small, single centre, randomised trial and analysed per protocol rather than by intention to treat. Patients with pre-existing liver disease were excluded. In this study both dobutamine and levosimendan increased indices of hepatic blood flow although the increase was greater with levosimendan. The SUrVIVE (Failure in need of Intravenous Inotropic Support) study used a similar protocol but in patients with heart failure 26 .
D. V. mUllAny
Anaesthesia and Intensive Care, Vol. 41, No. 6, November 2013 There are limited data on perioperative hepatic perfusion in cardiac surgery particularly those with a low cardiac output. one of the most important variables identified for postoperative hepatic decompensation is the preoperative Child Pugh grade 27 . Child C patients undergoing cardiac surgery have a guarded outcome 28 . In this study no patient had significant postoperative hepatic dysfunction although there was one late death in each group.
Assessment of liver blood flow is complicated by it dual blood supply and the technical aspects of imaging. Provision of normal values at baseline would be useful for those not familiar with the methods. The hepatic perfusion and haemodynamic data from the three patients in the dobutamine group and the four in the levosimendan group that were excluded would be of interest. Variability in response to dobutamine and hypotension from the loading dose +0.2 µg/kg/min infusion of levosimendan would not be unexpected. The role of milrinone in these patients also requires further evaluation 29 .
In Australia, levosimendan is available only through the Special Access Scheme; its use for cardiogenic shock would be considered off label and informed consent is required. It should be acknowledged that this would be a difficult study to conduct as a large trial.
Despite the limitations of the methods, these are interesting studies. The authors of all three papers discuss the limitations of their studies and provide valuable baseline data for larger prospective multicentre studies.
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